Skip to content
Clinical Trials – home
Verifiedinfo

Universidade De Santiago De Compostela

Spain Calle Choupana Da S/n, 15706 Santiago De Compostela, Spain

  • 205 trials recruiting
  • Dermatitis atopic · Non-small cell lung cancer · Psoriatic arthropathy
  • Adults and children

About Specializations

Universidade De Santiago De Compostela in Santiago De Compostela, Spain specialises in clinical trials of conditions such as Dermatitis atopic, Non-small cell lung cancer, Psoriatic arthropathy, Arteriosclerosis, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Blood Cancer Research

At Universidade De Santiago De Compostela, clinical research is focused on neoplasms, with a strong emphasis on hematology and cancers affecting the blood and lymphatic system. The studies are centered on treatment-naïve mantle cell lymphoma, exploring new approaches to improve outcomes for people newly diagnosed with this rare cancer.

  • Evaluating new treatment combinations for mantle cell lymphoma
  • Assessing how effectively therapies can produce deep remission in hematologic malignancies
  • Supporting better disease control for patients with newly diagnosed lymphoma

The research at this educational institution in Santiago De Compostela is aimed at testing whether modern treatment strategies can improve remission rates and strengthen care for patients with lymphoma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle Choupana Da S/n15706 Santiago De CompostelaSpain
Recruiting now
205 trials
Conditions studied
204
Partner status
Verified

More sites in Santiago De CompostelaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

598 clinical trials

Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Ferrer Internacional S.A.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:MOLNUPIRAVIR
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Diamedica Therapeutics Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prax-628
  • Sponsor:Praxis Precision Medicines Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).